Related Experiment Video
Updated: May 2, 2026

08:53
Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
8.8K
C9orf72 Repeat Expansion Induces Metabolic Dysfunction in Human iPSC-Derived Microglia and Modulates Glial-Neuronal
Marika Mearelli1,2, Insa Hirschberg1,2, Christin Weissleder3
1Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Glia
|September 1, 2025
Summary
The C9orf72 mutation disrupts cell metabolism in amyotrophic lateral sclerosis (ALS). Microglia show increased glycolytic activity and oxidative stress, impacting motor neuron vulnerability.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- The C9orf72 hexanucleotide repeat expansion is the leading genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia.
- Cell type-specific metabolic and immune pathway effects of this mutation are not well understood.
Purpose of the Study:
- To investigate cell type-specific metabolic alterations in induced pluripotent stem cell (iPSC)-derived neurons, astrocytes, and microglia from C9orf72 patients.
- To examine metabolic changes under basal and inflammatory conditions and their impact on intercellular communication.
Main Methods:
- Utilized iPSC-derived motor neurons, astrocytes, and microglia from C9orf72 patients and isogenic controls.
- Performed single-cell metabolic analysis under basal and inflammatory conditions.
- Developed a human iPSC-derived triculture system (motor neurons, astrocytes, microglia) to model intercellular effects.
Main Results:
- C9orf72 microglia exhibit heightened glycolytic activity, oxidative stress, and metabolic enzyme upregulation, unlike C9orf72 motor neurons with impaired mitochondrial respiration.
- Inflammatory stimuli exacerbate metabolic disturbances in C9orf72 microglia.
- Microglia-driven metabolic reprogramming in astrocytes contributes to motor neuron vulnerability in a triculture system.
Conclusions:
- Microglia play a central role in metabolic dysregulation and intercellular crosstalk in ALS pathogenesis.
- Targeting metabolic pathways in immune cells presents a potential therapeutic strategy for ALS.
Related Concept Videos
Pleiotropy
31.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
31.2K
Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K
Somatic to iPS Cell Reprogramming
2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28

